Disease | cytomegalovirus infections |
Phenotype | C0024299|lymphoma |
Sentences | 2 |
PubMedID- 22076952 | The potential role of pre-transplant hbcigg seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: a study from the rome transplant network. |
PubMedID- 26401238 | Reported that pre-transplant hbcigg seropositivity was a predictor of clinically relevant cmv infection in patients with lymphoma undergoing asct, with a 40% rate of cmv reactivation in hbcigg-positive patients compared to 9.8% in hbcigg-negative patients (p value, 0.008).17 this was not the case in our study, as the rate of cmv reactivation in the hbcigg-positive group was 15.2%, compared to 16.9% in the negative group (p value, 0.79). |
Page: 1